Memphis Pharmaceuticals (MPCI.CA) - Report of the Central Auditing Organization
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Report of the Central Auditing Organization on the financial statements for the financial period ending on 31/03/2024
The Central Auditing Organization Report (3,513 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Report of the Central Auditing Organization on the financial statements for the financial period ending on 31/03/2024
The Central Auditing Organization Report (3,513 KB)
Comments